veravanti.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | VerAvanti |
| Description | VerAvanti Inc. is developing a sub-millimeter, Scanning Fiber Endoscope (“SFE) to provide a first-ever, surgical view, into the intra-vascular anatomy. The real-time, high-definition images will enable cardiac interventionists to see the |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.49.23.144 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
veravanti.com Valuation
|
US$2,153,229
Last updated: 2022-07-05 19:37:14
veravanti.com has Semrush global rank of 4,915,551. veravanti.com has an estimated worth of US$ 2,153,229, based on its estimated Ads revenue. veravanti.com receives approximately 248,450 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, veravanti.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,153,229 |
| Daily Ads Revenue | US$1,988 |
| Monthly Ads Revenue | US$59,628 |
| Yearly Ads Revenue | US$715,535 |
| Daily Unique Visitors | 16,564 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| veravanti.com. | A | 3599 | IP: 198.49.23.144 |
| veravanti.com. | A | 3599 | IP: 198.185.159.145 |
| veravanti.com. | A | 3599 | IP: 198.49.23.145 |
| veravanti.com. | A | 3599 | IP: 198.185.159.144 |
| veravanti.com. | NS | 3600 | NS Record: ns1.yourhostingaccount.com. |
| veravanti.com. | NS | 3600 | NS Record: ns2.yourhostingaccount.com. |
| veravanti.com. | MX | 3600 | MX Record: 0 veravanti-com.mail.protection.outlook.com. |
| veravanti.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-07-05 19:37:14
| Home About Solutions Resources News Contact Home About Solutions Resources News Contact Illuminating Risks About Us Problem Solutions Medical Perspective Resources News Contact Illuminating Risks Today in Advanced Care Facilities Worldwide: The origin of 33% of ischemic strokes is unclear. Only 20% of Chronic Total Occlusion (CTO) patients receive therapy. We are using advanced science to close these treatment gaps. SCROLL DOWN Illuminating Risks Today in Advanced Care Facilities Worldwide: The origin of 33% of ischemic strokes is unclear. Only 20% of Chronic Total Occlusion (CTO) patients receive therapy. We are using advanced science to close these treatment gaps. See It Understand It Treat It About Us VerAvanti is developing a new medical device called a Scanning Fiber Endoscope (SFE). The patented- SFE offers the potential for interventional cardiologists to reduce sightline gaps that are critical to proactively diagnosing and treating individuals at-risk for stroke and |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 123655 Date: Wed, 27 Oct 2021 19:07:17 GMT Location: https://veravanti.com/ Server: Squarespace Set-Cookie: crumb=BeekB4fpR7jRNjkxYWU3Zjk3ZjU0NGE4NjdjNmZkMzg1MzRlOGI1;Path=/ X-Contextid: UnhFhUMs/fDuARPsv HTTP/2 200 accept-ranges: bytes age: 126754 content-type: text/html;charset=utf-8 date: Wed, 27 Oct 2021 18:15:38 GMT etag: W/"5a065fcc22fc31d6fc9d6d7e99cdb242" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BRAgnOvittDZZGFkNGI2ODc2MDdmNjg1OTExOWRlOWQ1ZGJjNjc1;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: OnSt7aKC/OYYCcUvF content-length: 22904 |
veravanti.com Whois Information
Domain Name: VERAVANTI.COM Registry Domain ID: 1608170510_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2021-07-10T14:57:09Z Creation Date: 2010-07-25T19:02:56Z Registry Expiry Date: 2022-07-25T19:02:56Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.DOTSTER.COM Name Server: NS2.DOTSTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T19:48:58Z <<< |